NEW YORK, NY (Marketwired – Aug 27, 2014)
As predicted earlier this year, prostate cancer is continuing its strong presence among U.S. men. While the American Cancer Society predicts that more than 230,000 men will be diagnosed with prostate cancer this year, outcomes remain positive. David B. Samadi, MD, Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital, encourages men to stay educated about prostate cancer risk factors and screening opportunities.
“When diagnosed early, prostate cancer is highly treatable, though it is still a dangerous cancer that deserves continued attention,” said Dr. Samadi, a leading New York robotic prostate surgeon. “Its reputation as a silent killer stems from the limited warning signs. Because of that, men must work closely with their healthcare providers to identify all possible red flags.”
“This information is important, but there are critical facts about prostate cancer for men to remember: prostate cancer is highly common, highly detectable, and highly treatable,” said Dr. Samadi. “About one in seven men will develop prostate cancer within their lifetime, but in partnership with a prostate cancer expert, men remain in control of diagnosis and treatment and, ultimately, recovery.”
David B. Samadi, MD, performs expert robotic prostate surgery at Lenox Hill Hospital in New York. To date, he has performed more than 5,600 successful robotic prostate removal procedures and 89 percent (unless you can cite the study/report that found this exact number, you cannot make that claim) of his patients are cancer free after surgery. His patients enjoy full-circle support and most experience very positive urinary control and sexual function results after surgery.Press Release